Pfizer’s Drug Safety Web Site Aims To Reclaim Risk Communication Authority
Executive Summary
BOSTON-Pfizer's new Medicine Safety Web site is the first attempt by a pharmaceutical company to reclaim authority over risk communication from FDA
You may also be interested in...
FDA Amendments Act Implementation Faces Delay; Agency To Miss Deadlines
FDA is expected to miss a spate of implementation deadlines for provisions of the FDA Amendments Act as the law approaches its first anniversary
Extra Caution Needed In Uncertain Period For Off-label Info Distribution
In off-label promotion investigations, OIG looks for kickback issues or other bad conduct and whether there is patient harm.
FDA List Of Potential Safety Signals Has 3 Pfizer Drugs, Echoes Drug Watch Site
FDA's quarterly report that lists potential signals of serious risks for drugs is similar in design to a program that the agency proposed and then withdrew following industry criticism